Many thanks to our amazing collaborators Naftali Kaminski and Ivan Rosas and their teams for the creation of this very important resource on pulmonary fibrosis. Every gene that's measured, every paper that's written, gets us one step closer to #CurePF ! buff.ly/2ZMXvGg

NuMedii CEO speaking at the UN on #InternationalWomensDay #WomenInSTEM

What great news for one of my hero companies. They are helping lead the way in the fight to find a cure for PF. Gini Deshpande #curePF #PFWarriors

Excited that this collaboration enables us to advance our pipeline and create new therapeutic options! #patients #collaboration #ulcerativecolitis #AI #drugdiscovery
prnewswire.com/news-releases/…

Thrilled to see the results of our collaborative work with Naftali Kaminski and Rosas labs out! cc Jonas Schupp, Sergio Poli and Taylor Adams

#BioPharmUSA panelists speak on the challenges in the application of #AI and Machine Learning in #drugdiscovery . See the full program now>> spr.ly/6018EfZWe Envisagenics Recursion Ron Alfa NuMedii
Nuritas Paul Rohricht MS MBA Bristol Myers Squibb Joseph Szustakowski Pfizer Inc.

Congratulations to NuMedii cofounder Atul Butte for the AIMBE award in recognition of his 'outstanding contributions to creating a #precisionmedicine roadmap with #openaccess data, enabling the discovery of novel therapeutics and diagnostics'!

Attending Precision Med TRI-CON 2019? Don't miss our CTO, Asim Siddiqui's talk at noon on 'Practical Applications of #AI to drug discovery' bit.ly/2XSOZUf

Video for those that missed a great panel on '“Demystifying AI in Pre-clinical Drug Design and Discovery” Peter M. Cahill with NuMedii CEO Gini Deshpande, Numerate CTO Almeda 225, Daphne Koller, Eric Morgen and a16z's Vijay Pande

And announcing a new collaboration with Dr. Jay Pasricha Johns Hopkins Medicine! prn.to/2JvgwVf

Excited to welcome our new VP of Research, Heather Arnett, PhD! prn.to/2RpeTuO

Congratulations to our #BoardOfDirectors member Dr Athena Countouriotis who has taken on #CEO role @TPTherapeutics and raised $80M financing led by Foresite Capital + venBio Partners! #WomenOnBoard #womenleaders

#tbt to January when Dr. David Schwartz of CU School of Medicine and Dr. Kevin Brown of National Jewish Health were elected to NuMedii's advisory board!

Congratulations to our #IPF advisor Gisli Jenkins for the prestigious NIHR Research Professorship! #PrecisionMedicine #bigdata #translationalmedicine in #IPF bit.ly/2NrxV1I

Excited to announce our new collaboration in IPF using single cell sequencing with Naftali Kaminski Yale School of Medicine and Dr. Ivan Rosas Brigham and Women's Hospital! Deepening our discovery efforts with the aim of developing #precisiontherapies prn.to/2NHV5BI

We have strengthened our BoD with the addition of Dr. Athena Countouriotis and welcome new SAB member Dr. Zemin Zhang. Excited to have these two oncology experts join us! prn.to/2K3sAME

.NuMedii started w/ #opendata , now w/ @Allergan, @3LakesPartners→ new drugs! buff.ly/2qJbL0k 👍🏽Gini Deshpande @UAMSHealth #Rockefeller18

Our CEO Gini Deshpande highlights our collaboration with @3LakesPartners as 'a model going forward for a lot of biotechs'. Profiled in the The Wall Street Journal: on.wsj.com/2IGV9zd

In good company! twitter.com/gausssurgical/…

Our CTO, Asim Siddiqui's talk on #PrecisionMedicine at #PMWC18 is standing room only! #ArtificialIntelligence is THE trend for 2018 twitter.com/biotechfounder…